---

$42.78

-0.1300 ( -0.30% ) 660.8K

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2024-01-18	Sale	-26250.00	Grant Sean
2024-01-12	Sale	-1050000.00	COMMODORE CAPITAL LP
2024-01-09	Sale	-275000.00	Turner William D.